Specifically, we explored the mechanism of interaction between Noxa1 and ferroptosis in relation to radioresistance in CRC and explored the feasibility of using Noxa1 as a biomarker for radioresistance. The gene discussed is NOXA1; the disease is colorectal carcinoma.